← Browse by Condition
Medical Condition

larynx squamous cell carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07063212 Phase 2
Recruiting

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Enrollment
40 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →